Verigat Tablet 10 mg contains Vericiguat, a potent soluble guanylate cyclase (sGC) stimulator designed for the treatment of chronic heart failure with reduced ejection fraction (HFrEF). This high-strength formulation is intended for patients who require maximum therapeutic benefit after titration from lower doses. Vericiguat improves heart function, reduces the risk of heart failure-related hospitalizations, and enhances overall quality of life in patients who continue to experience symptoms despite standard heart failure therapies.

Chronic heart failure occurs when the heart cannot pump blood efficiently, resulting in fatigue, shortness of breath, fluid retention, and reduced exercise capacity. Vericiguat addresses the underlying mechanisms of heart failure by stimulating the NO-sGC-cGMP pathway, promoting vasodilation, and enhancing myocardial efficiency.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Mechanism of Action

Vericiguat works by stimulating soluble guanylate cyclase (sGC), an enzyme in the nitric oxide (NO) signaling pathway:

• Increases cyclic guanosine monophosphate (cGMP) levels, leading to relaxation of blood vessels

• Reduces vascular resistance and afterload, improving cardiac output

• Enhances myocardial efficiency and reduces cardiac stress

• Slows cardiac remodeling, helping preserve heart function

• Works synergistically with standard heart failure medications for improved patient outcomes

By targeting both vascular and cardiac mechanisms, Verigat helps alleviate symptoms and slows progression of heart failure.

Indications

Verigat Tablet 10 mg is indicated for:

• Chronic heart failure with reduced ejection fraction (HFrEF)

• Patients who remain symptomatic despite standard therapy including ACE inhibitors, ARBs, beta-blockers, and mineralocorticoid receptor antagonists

• Reduction of heart failure-related hospitalizations

• Improving functional capacity, quality of life, and cardiovascular outcomes in high-risk patients

This high-dose formulation is typically prescribed after patients have successfully tolerated lower doses and require further therapeutic effect.

Dosage and Administration

• Therapy typically begins at 2.5 mg once daily, gradually titrated to 5 mg, and then to 10 mg once daily as tolerated.

• Tablets should be taken orally, with or without food, and swallowed whole with water.

• Regular monitoring of blood pressure, kidney function, and heart failure symptoms is recommended during titration and maintenance.

• Adherence to prescribed dosage and follow-up visits is crucial for safety and efficacy.

Precautions

• Use only under medical supervision, particularly in patients with hypotension, severe renal or hepatic impairment, or electrolyte disturbances.

• Inform your doctor of all medications being taken, as Vericiguat may interact with drugs affecting blood pressure or heart function.

• Not recommended during pregnancy or breastfeeding unless specifically advised by a healthcare professional.

• Monitor for signs of dizziness, fainting, or low blood pressure.

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Possible Side Effects

Common side effects may include:

• Hypotension (low blood pressure)

• Dizziness or lightheadedness

• Headache

• Fatigue

Serious but rare side effects include worsening heart failure, syncope, or severe hypotension. Seek immediate medical attention if severe symptoms occur.

Storage

Store Verigat Tablet 10 mg in a cool, dry place, protected from sunlight and moisture. Keep out of reach of children.

Verigat Tablet 10 mg is an effective therapy for advanced chronic heart failure, improving cardiac function, reducing hospitalizations, and enhancing the quality of life in patients with reduced ejection fraction when used under proper medical supervision.